|
|
|
Volumn 6, Issue 3, 1997, Pages 113-126
|
|
Obstacles to the development of dengue virus vaccines: Enhancement of disease by neutralizing antiviral antibodies and virus evolution?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DENGUE VACCINE;
NEUTRALIZING ANTIBODY;
VIRUS ANTIBODY;
ARTICLE;
DENGUE VIRUS;
DISEASE SEVERITY;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
DRUG STABILITY;
HUMAN;
IMMUNE RESPONSE;
MORBIDITY;
MORTALITY;
NONHUMAN;
PATHOGENESIS;
PRIORITY JOURNAL;
TROPICS;
VACCINE PRODUCTION;
VIROGENESIS;
VIRUS INFECTION;
VIRUS PARTICLE;
|
|
EID: 0031430132
PISSN: 10567909
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (158)
|
